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ABSTRACT
Objective: To evaluate the effectiveness of hyaluronic acid in the healing of partial 
thickness burns. Method: Systematic review of randomized controlled trials on the use of 
hyaluronic acid for the topical treatment of skin burns, based on recommendations of the 
Cochrane Handbook for Systematic Reviews of Interventions. Results: Two randomized 
controlled trials that analyzed 143 patients with partial thickness burns and/or deep 
partial thickness burns were selected. They compared the application of hyaluronic acid 
0.2% associated to silver sulfadiazine 1% 5g/cm2 versus silver sulfadiazine 1% 5g/cm2 
alone for the outcome of complete healing. Conclusion: This review emphasizes the need 
for new well-designed randomized controlled trials to establish the therapeutic relevance 
of hyaluronic acid with respect to the healing of burns of partial thickness or deep partial 
thickness.
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INTRODUCTION
Wounds are defined as a solution of continuity of the 
skin or adjacent tissues originating from physical, chemi-
cal or thermal damage(1). The treatment of these injuries 
involves the use of covers, an advanced method(2) that uses 
products ideally obtained from biological components that 
are minimally handled, non-toxic, hypoallergenic and en-
able removal of the product without further tissue damage. 
Moreover, the covers must provide a moist environment, 
promote gas exchange, prevent bacterial development, con-
trol excessive exudate(3), and maintain constant local tem-
perature(4) without need for routine change(5).
In this context, hyaluronic acid stands out as a new 
technology for treating dermal and epidermal injuries. It 
consists of biological materials derived from components 
extracted of the extracellular matrix(6). Hyaluronic acid has 
essential features to any biological coverage such as bio-
compatibility and biodegradability, plus it does not induce 
immunogenicity(7-8).
As a therapeutic agent, hyaluronic acid is used in nu-
merous applications, among which eye surgery, tissue recon-
struction(9-10), degenerative and inflammatory joint diseases, 
synovial fluid replacement, release of chemical agents in 
surgical implants, systems of encapsulation and controlled 
release of drugs and topical cosmetics(11). In local treatment 
of wounds, it is used in the form of cream, gel, or impreg-
nated gauze to promote healing(12).
Burns are a peculiar group of wounds treated with hyal-
uronic acid. They are a traumatic injury resulting from direct 
or indirect action of thermal energy on the human body 
that leads to tissue destruction. Burns may develop into a 
chronic debilitating condition with morbidity and signifi-
cant mortality(13).
Etiologically, burns are triggered by various agents, such 
as heat, radiation, cold, radioactivity, electricity, friction or 
exposure to chemicals(14). The mechanism or etiology of in-
juries, grade, depth of tissue involvement, and extent of body 
surface area burned are considered for their classification(15).
The aim of the treatment is mainly to accelerate healing 
and control the excessive deposition of collagen in scar tis-
sue to prevent the occurrence of contractures and keloids(16). 
Suitable topical therapy of a burn injury considers using prod-
ucts to control bacterial growth, remove devitalized tissue 
and promote healing(17). The selection of dressings is based 
on the effects on healing, ease of application and removal of 
the product, the cost of treatment, and patient’s comfort(18).
The successful treatment leads to recovery of physiologi-
cal function, alleviation or elimination of symptoms such 
as pain or itching, and aesthetic and functional restoration 
of injuries without the occurrence of hypertrophic scars 
or keloids(19).
Given the impact of burns on survivors and the com-
plexity of treatment, it is necessary to search for scientific 
evidences to support the best clinical decision. Thus, the 
objective of this review is to evaluate the effectiveness of 
hyaluronic acid in the healing of burns of partial thickness 
or deep partial thickness.
METHOD
This is a systematic review of randomized controlled 
trials based on the recommendations of the Cochrane 
Handbook for Systematic Reviews of Interventions pro-
posed by the Cochrane Collaboration. A systematic review 
is a type of secondary study performed from a defined re-
search question. By using the question, the aim is to identify, 
evaluate, select and synthesize evidence from primary stud-
ies that meet the predefined eligibility criteria(20).
For the elaboration of the research question was used 
the acronym PICO(21) (P – population or problem, I – in-
tervention; C – comparison; O – outcomes) in which: P 
– Hospitalized patients with partial thickness burns and/or 
deep partial thickness burns, regardless of the mechanism of 
injury, depth, location or body surface area burned; I – use of 
hyaluronic acid; C – Different concentrations and formula-
tions of hyaluronic acid, placebo, standard treatment, and 
other types of dressings; O – Healing. Thus, the research 
question was: What is the effectiveness of hyaluronic acid in the 
healing process of burns of partial thickness and/or deep partial 
thickness in hospitalized patients?
This review included randomized controlled trials, pub-
lished or not, with any sample size that contemplated the 
adoption of hyaluronic acid in the treatment of skin burns 
of partial thickness or deep partial thickness, regardless of 
the mechanism of injury, depth, location or body surface 
area burned in hospitalized children, adolescents, adults 
and elderly.
Studies involving other etiologies of wounds, not lim-
ited to the use of hyaluronic acid intervention, and other 
study designs that not randomized trials were excluded.
The relevant studies were found by searching in the fol-
lowing electronic databases: Medical Literature Analysis and 
Retrieval System Online/PubMed (MEDLINE), Cumulative 
Index to Nursing and Allied Health Literature (CINAHL), 
Web of Science, Literature in the Health Sciences in Latin 
American and the Caribbean (LILACS), Cochrane Central 
Register of Controlled Trials (CENTRAL) and Excerpta 
Medica Database (EMBASE). There were no restrictions 
concerning the date of publication or language.
Complementarily, was performed a manual search for 
gray literature, which consists of studies not controlled by 
scientific or commercial publishers, such as government 
reports, theses, dissertations and abstracts published in 
conference proceedings. The reference lists of the clinical 
studies found were examined to identify potentially eligible 
studies that were not found in the search strategy.
We selected the descriptors and their synonyms in 
Portuguese and English for the search of primary stud-
ies in the previously established databases: Medical Subject 
Headings (MeSH) – hyaluronic acid, or hyaluronate, or hyal-
uronan; and burn, or burns; and randomized controlled trial; 
Health Sciences Descriptors (DeCS) ‘ácido hialurônico’; and 
‘queimaduras or queimadura’; combined using Boolean op-
erators AND, OR, added to truncation symbols that formed 
the basis of the search equation, later adapted to the speci-
fications of each base.
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For inclusion, the abstracts of the identified studies 
were assessed blindly and independently by two review-
ers, who applied the eligibility criteria and selected the 
relevant studies. In case of disagreement, a third reviewer 
was requested. In the first consensus meeting, the selected 
studies were assessed in full with application of eligibil-
ity criteria. Subsequently, in the second consensus meet-
ing were defined the studies included and excluded from 
the review. The Kappa coefficient(22) was used to assess the 
interobserver agreement with score range between 1 (com-
plete agreement) and – 1 (complete disagreement). During 
consensus meetings, there was support from a third reviewer 
for disagreements between reviewers.
The selection was composed of two phases: a) first 
screening, evaluation of the titles and abstracts of all iden-
tified studies; b) reading in full: evaluation of the full text.
For data extraction, was developed a form to summarize 
information of the studies, which included identification, 
method, participants, clinical characteristics, intervention, 
comparison, clinical outcomes, ethical issues and financing.
The assessment of methodological quality of the select-
ed studies was conducted by the Cochrane Collaboration’s 
tool for assessing the risk of bias in randomized controlled 
trials available in the Review Manager version 5.3(23). In 
this evaluation, the studies were judged as ‘low risk of bias’, 
‘high risk of bias’, and ‘unclear risk of bias’ for the domains: 
generation of random sequence (selection bias), allocation 
concealment (selection bias), blinding of participants and 
professionals (performance bias), blinding of outcome as-
sessors (detection bias), incomplete outcomes (attrition 
bias),and selective outcome reporting (reporting bias).
There was no conflict of interest nor any kind of funding 
for conducting this review.
RESULTS
The search strategies resulted in 69 studies. Of this 
amount, 20 were published in more than an electronic base 
and 45 did not meet the inclusion criteria. Thus, four stud-
ies were evaluated in full. After independent analysis by 
two reviewers, two studies were included in this review, as 
shown in Figure 1. The score of interobserver concordance 
rate (Kappa) on the inclusion or exclusion of studies was 
0.877 (p = <0.001), indicating agreement reliability between 
the two reviewers.
Fifteen articles were eliminated because they were ex-
perimental studies, five were in vitro studies, six assessed the 
treatment of corneal burns, two of the tympanic membrane, 
an application of intra-articular hyaluronic acid, an applica-
tion of intra-abdominal hyaluronic acid, and a study about 
rhinoplasty. A case report about burn treatment with dermal 
substitute was also excluded, as well as a pilot study on hyal-
uronic acid, a study evaluating the pH of burns, one on the 
use of Aloe Vera in thermal injuries, four studies that applied 
dermal matrix, a systematic review about diabetic foot, a sys-
tematic review on hyaluronic acid, a study on venous ulcers, a 
study using dressings with silver sulfadiazine, and a nonran-
domized controlled trial. One of the pre-selected studies was 
not obtained with full text, so it was excluded of the review.
In the second consensus meeting, a previously selected 
controlled trial was excluded by applying hyaluronic acid in 
the graft donor area, and not in the burns. Another study 
was excluded because it did not present the specific results 
of hyaluronic acid for the treatment of burns among the 
various types of injuries included.
MEDLINE/PubMed – 31
EMBASE – 8
Cochrane – 11
Web of Science – 11
CINAHL – 8
LILACS – 0
Additional records identified in other
sources (manualsearch) – 0
Duplicate articles – 20
Selected studies – 4 Excluded studies – 45
Full articles evaluated according 
to eligibility criteria – 4
Studies included in the qualitative 
analysis – 2
Full articles excluded – 2
One study evaluated hyaluronic
acid in the graft donor area, and
not in burns. One study showed 
no specific results in burns, 
among various types of injuries 
evaluated.
Figure 1 – Flowchart of identification, selection and inclusion of 
studies – Curitiba, PR, Brazil, 2016.
In the individual assessment of methodological quality 
(Figure 2), a randomized controlled trial presented the do-
main assessment of outcomes classified as unclear risk of bias 
because information about the blinding of outcome asses-
sors was not evident in the report(24). In turn, the other study 
did not have any domain with low risk of bias(25).
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Legend: + ‘low risk of bias’; – ‘high risk of bias’; ? ‘unclear risk of bias’.
Figure 2 – Individual assessment of the methodological quality 
of the studies included in the systematic review – Curitiba, PR, 
Brazil, 2016.
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In the first domain, both studies describe the use of a 
computer program to obtain the allocation sequence. For 
allocation concealment, the authors only provided informa-
tion describing the clinical similarity between participants 
in controls and intervention groups.
The blinding of participants and professionals was de-
clared in both studies through the standardization of pack-
aging and compatibility characteristics of topical agents 
(Intervention ‒ Hyaluronic acid cream 0.2% and silver 
sulfadiazine 1% 5g/cm2, or Control – silver sulfadiazine 
1% 5g/cm2).
In the domain assessment of outcomes, one of the articles 
does not state where analytical data were treated, which 
configures unclear risk of bias for this domain(24).
In both evaluated studies, the selection of outcome re-
ports or incomplete information were not identified in the 
results. All the outcomes mentioned in the methodology 
were reported in the analysis, thus categorizing low risk of 
bias for this domain.
Chart 1 shows the selected studies with the respective 
references, publication year, country, design and number of 
patients evaluated.
Chart 1 – Studies selected according to the reference, year, coun-
try, design and number of patients – Curitiba, PR, Brazil, 2016.
Study Reference Year/Country
Design/number 
of patients
Koller(24)
Koller J. Topical treatment 
of partial thickness burns 
by silver sulfadiazine 
plus hyaluronic acid 
compared to silver 
sulfadiazine alone: a 
double-blind, clinical 
study. Drugs Exp Clin 
Res, 2004; 5, 183-190.
2004/
Slovakia
Randomized 
controlled trial 
double blind/
n=33
Costagliola 
and 
Agrosi(25)
Costagliola M, Agrosi M. 
Second-degree burns: a 
comparative, multicenter, 
randomized trial of 
hyaluronic acid plus 
silver sulfadiazine vs. 
silver sulfadiazine alone. 
Curr Med Res Opin, 
2005; 21(8): 1235-40.
2005/
France,
Croatia, 
Slovenia 
and 
Germany
Multinational 
controlled 
clinical trial, 
multicenter, 
double blind/
n=111
A study included patients aged between 18 and 80 years, 
mean of 35 (±14.5) years for the intervention group, and 
40.7 (±11.6) years in the control group. There were no clini-
cal or laboratory abnormalities, except for those caused by 
the thermal injury(24).
The second study included patients aged between 18 
and 75 years, mean of 38.2 (±12.4) years in the interven-
tion group, and 38.5 (±13.7) years in the control group. The 
follow up of one patient was lost during the study(25). The 
clinical inclusion and exclusion criteria were identical in 
both studies.
In relation to injuries, randomized patients of the first 
study had partial thickness burns or deep partial thick-
ness burns, with between 5 and 11% of body surface area 
burned(24). Patients of the second study had burns of partial 
thickness and/or deep partial thickness with body surface 
area burned of less than 5%(25).
Regarding comparison, both studies evaluated the as-
sociation between hyaluronic acid cream 0.2% and silver 
sulfadiazine 1% 5g/cm2 versus silver sulfadiazine 1% 5g/cm2 
applied weekly for 28 days. The primary outcome was the 
average healing time(24-25).
A study showed 8.167 (± 2.684) days as mean time 
for complete healing of wounds in the intervention group, 
while in the control group 13.067 (± 5.203) days were need-
ed for the total healing(24). This difference was statistically 
significant (p = 0.001) in favor of the intervention group. 
In another clinical trial study, the average healing time was 
9.5 (± 1.28) days in the intervention group compared to 14 
(± 0.51) days in the control group(25).
DISCUSSION
The aim of this systematic review was to evaluate the ef-
fectiveness of hyaluronic acid in complete healing of partial 
thickness and/or deep partial thickness burns compared to 
other covers and/or solutions. In this context, 143 patients 
were analyzed in two randomized controlled trials, random-
ly distributed for the outcome of complete healing.
There was a statistically significant difference in mean 
healing time in favor of intervention groups compared 
to controls(24-25). The inconsistency test demonstrated 
by the Review Manager 5.3 program of the Cochrane 
Collaboration showed heterogeneity of 97%, hence it was 
not possible to perform the meta-analysis between studies 
for the outcome of average healing time.
In a systematic review, were evaluated topical formula-
tions containing hyaluronic acid for the treatment of chron-
ic wounds of various etiologies, such as thermal injury, ve-
nous ulcers and diabetic foot. It was found that the product 
promotes healing when compared to other treatments(26).
In a randomized controlled trial, the efficacy of hyal-
uronic acid in the treatment of venous ulcers was compared 
to a neutral carrier. The primary outcome was the percent-
age reduction of the wound size at 45 days. It was found 
that the reduction of the ulcer surface area was significantly 
higher in the intervention group (73 ± 4.6%) versus the con-
trol group (46 ± 9.6%) (P = 0.011). The number of healed 
ulcers in the intervention group was higher at day 45 (31% 
vs. 9%, respectively) and day 60 (37% vs. 16%, respectively) 
(P<0.05)(12).
Specifically in thermal injuries, a cohort study with 60 
patients with partial thickness burns found an average re-
duction of 50% in the size of the wound in the first five 
follow up days of combined application of hyaluronic acid 
with zinc. Complete healing occurred in 93.3% of the sam-
ple after 21 days of follow up, with an average healing time 
of 10.5 days(27).
A retrospective study evaluated the clinical efficacy of 
grafting with goat dermal matrix combined with hyaluron-
ic acid in five patients with extensive full thickness burns. 
Patients were submitted to nine skin micrograft applica-
tions covering 17 members. The average time of devitalized 
tissue peeling was 17.7 (± 2.7) days and the hospitalization 
time was 115 (± 27) days. After 72 (± 6) days, the residual 
wound was less than 5% of body surface(28).
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In experimental studies, hyaluronic acid demonstrates 
superiority compared to other covers, with respect to 
shorter time of wound healing and histological character-
istics such as improved elasticity and higher microvascu-
lar density(29-30).
When hyaluronic acid is applied in wounds, there is im-
proved water retention, which favors a suitable environment 
for the formation of collagen and elastin, and allows the 
cells to proliferate and differentiate, accelerating the heal-
ing process(31).
Furthermore, the anti-inflammatory properties of hy-
aluronic acid influence the healing, preventing the conver-
sion of wound(32-33) and formation of hypertrophic scars 
or keloids(34).
Another relevant aspect for the application of hyal-
uronic acid is the fact of biomaterial being a non-immu-
nogenic substance. An experimental study was conducted 
to determine the skin tolerance to topical application of 
hyaluronic acid in full thickness injuries (35% of the body 
surface area), and it showed the substance was well tolerated 
and there were no adverse or side effects(35).
CONCLUSION
The results of this systematic review show the lack of 
sufficient evidence in the literature to support the use of 
hyaluronic acid in the topical treatment of burns. Given the 
above, this review emphasizes the need for well-designed 
randomized controlled trials to establish the therapeutic 
relevance in the healing of partial thickness burns or deep 
partial thickness burns, and thus incorporate hyaluronic 
acid to clinical practice.
However, the topical action of the combination of hy-
aluronic acid and silver sulfadiazine showed significantly 
favorable response in relation to the average healing time 
of partial thickness burns or deep partial thickness burns. In 
addition, there was no occurrence of adverse effects or side 
effects, thus suggesting the possibility for the clinical use of 
the product in terms of effectiveness and safety.
RESUMO
Objetivo: Avaliar a efetividade do ácido hialurônico na cicatrização de queimaduras de espessura parcial. Método: Revisão sistemática 
de ensaios clínicos randomizados sobre a utilização de ácido hialurônico no tratamento tópico de queimaduras de pele, baseada nas 
recomendações do Cochrane Handbook for Systematic Reviews of Interventions. Resultados: Foram recuperados dois ensaios clínicos 
randomizados que analisaram 143 pacientes portadores de queimaduras de espessura parcial e/ou espessura parcial profunda, comparando 
a aplicação de Ácido Hialurônico 0,2% associado à Sulfadiazina de Prata 1% 5g/cm2, versus Sulfadiazina de Prata 1% 5g/cm2 isolada, 
para o desfecho cicatrização completa. Conclusão: Esta revisão enfatiza a necessidade de novos ensaios clínicos randomizados bem 
delineados para estabelecimento da relevância terapêutica do ácido hialurônico no que tange à cicatrização de queimaduras de espessura 
parcial ou espessura parcial profunda.
DESCRITORES
Ácido Hialurônico; Queimaduras; Cicatrização; Enfermagem Baseada em Evidências; Revisão.
RESUMEN
Objetivo: Evaluar la efectividad del ácido hialurónico en la cicatrización de quemaduras de espesor parcial. Método: Revisión sistemática 
de ensayos clínicos randomizados acerca de la utilización de ácido hialurónico en el tratamiento tópico de quemaduras de piel, basada 
en las recomendaciones del Cochrane Handbook for Systematic Reviews of Interventions. Resultados: Fueron recuperados de los ensayos 
clínicos randomizados que analizaron 143 pacientes portadores de quemaduras de espesor parcial y/o espesor parcial profundo, 
comparando la aplicación de Ácido Hialurónico al 0,2%, asociado con la Sulfadiazina de Plata al 1% 5g/cm2, versus Sulfadiazina de 
Plata al 1% 5g/cm2 aislada, para el resultado de una cicatrización completa. Conclusión: Esta revisión subraya la necesidad de nuevos 
ensayos clínicos randomizados bien planteados para el establecimiento de la relevancia terapéutica del ácido hialurónico en lo que se 
refiere a la cicatrización de quemaduras de espesor parcial o espesor parcial profundo.
DESCRIPTORES
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